BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Clinical Outcome
25 results:

  • 1. Prediction of liver-Related Events With a Combination of liver Stiffness Measurements and Controlled Attenuation Parameters in Japanese Patients With Biopsy-Proven Non-alcoholic Fatty liver Disease.
    Hayashi H; Kamada Y; Fujii H; Takahashi H; Oeda S; Iwaki M; Kawaguchi T; Tomita E; Yoneda M; Tokushige A; Ueda S; Aishima S; Sumida Y; Nakajima A; Okanoue T;
    Ultrasound Med Biol; 2023 Jul; 49(7):1658-1664. PubMed ID: 37120329
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. clinical outcome and Utilization Profiles Among Latent Groups of High-Risk Patients: Moving from Segmentation Towards Intervention.
    Hutchins F; Thorpe J; Maciejewski ML; Zhao X; Daniels K; Zhang H; Zulman DM; Fihn S; Vijan S; Rosland AM
    J Gen Intern Med; 2022 Aug; 37(10):2429-2437. PubMed ID: 34731436
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non-Small Cell Lung cancer.
    Smit J; Borm FJ; Niemeijer AN; Huisman MC; Hoekstra OS; Boellaard R; Oprea-Lager DE; Vugts DJ; van Dongen GAMS; de Wit-van der Veen BJ; Thunnissen E; Smit EF; de Langen AJ
    J Nucl Med; 2022 May; 63(5):686-693. PubMed ID: 34385342
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer.
    Kwan KH; Burvenich IJG; Centenera MM; Goh YW; Rigopoulos A; Dehairs J; Swinnen JV; Raj GV; Hoy AJ; Butler LM; Scott AM; White JM; Ackermann U
    Nucl Med Biol; 2021 Feb; 93():37-45. PubMed ID: 33310350
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of Bridging Locoregional Therapies for Hepatocellular Carcinoma on Post-transplant clinical outcome.
    Adeniji N; Arjunan V; Prabhakar V; Tulu Z; Kambham N; Ahmed A; Kwo P; Dhanasekaran R
    Clin Transplant; 2020 Dec; 34(12):e14128. PubMed ID: 33098134
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology.
    Strazzabosco M; Cortesi PA; Conti S; Okolicsanyi S; Rota M; Ciaccio A; Cozzolino P; Fornari C; Gemma M; Scalone L; Cesana G; Fabris L; Colledan M; Fagiuoli S; Ideo G; Zavaglia C; Perricone G; Munari LM; Mantovani LG; Belli LS
    Liver Int; 2020 Jan; 40(1):60-73. PubMed ID: 31654608
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Low vitamin D at ICU admission is associated with cancer, infections, acute respiratory insufficiency, and liver failure.
    Gomes TL; Fernandes RC; Vieira LL; Schincaglia RM; Mota JF; Nóbrega MS; Pichard C; Pimentel GD
    Nutrition; 2019 Apr; 60():235-240. PubMed ID: 30682545
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Single-centre experience of extending indications for percutaneous intraportal islet autotransplantation (PIPIAT) after pancreatic surgery to prevent diabetes: feasibility, radiological aspects, complications and clinical outcome.
    Venturini M; Sallemi C; Colantoni C; Agostini G; Balzano G; Esposito A; Secchi A; De Cobelli F; Falconi M; Piemonti L; Maffi P; Del Maschio A
    Br J Radiol; 2016 Aug; 89(1064):20160246. PubMed ID: 27327404
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal liver Metastases (CRLM): Looking Beyond the Tumor Margin.
    Siriwardana PN; Luong TV; Watkins J; Turley H; Ghazaley M; Gatter K; Harris AL; Hochhauser D; Davidson BR
    Medicine (Baltimore); 2016 Feb; 95(8):e2924. PubMed ID: 26937938
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib.
    Casadei Gardini A; Marisi G; Scarpi E; Scartozzi M; Faloppi L; Silvestris N; Masi G; Vivaldi C; Brunetti O; Tamberi S; Foschi FG; Tamburini E; Tenti E; Ricca Rosellini S; Ulivi P; Cascinu S; Nanni O; Frassineti GL
    Expert Opin Pharmacother; 2015; 16(18):2719-25. PubMed ID: 26513009
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Potentially Important Extracolonic Findings at Screening CT Colonography: Incidence and outcomes Data From a clinical Screening Program.
    Pooler BD; Kim DH; Pickhardt PJ
    AJR Am J Roentgenol; 2016 Feb; 206(2):313-8. PubMed ID: 26491809
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate cancer Pretreated With Docetaxel Chemotherapy: A Prostate cancer clinical Trial Consortium Study.
    Vaishampayan U; Shevrin D; Stein M; Heilbrun L; Land S; Stark K; Li J; Dickow B; Heath E; Smith D; Fontana J
    Urology; 2015 Dec; 86(6):1206-11. PubMed ID: 26375845
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With clinical outcome.
    Tirumani SH; Sakellis C; Jacene H; Shinagare AB; Munshi NC; Ramaiya NH; Van den Abbeele AD
    Clin Nucl Med; 2016 Jan; 41(1):e7-13. PubMed ID: 26252323
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases.
    Stremitzer S; Zhang W; Yang D; Ning Y; Stintzing S; Sebio A; Sunakawa Y; Yamauchi S; Matsusaka S; El-Khoueiry R; Stift J; Wrba F; Gruenberger T; Lenz HJ
    Cancer; 2015 Jun; 121(11):1898-905. PubMed ID: 25690670
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The clinical impact of uncertainties in the mean excitation energy of human tissues during proton therapy.
    Besemer A; Paganetti H; Bednarz B
    Phys Med Biol; 2013 Feb; 58(4):887-902. PubMed ID: 23337713
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Percutaneous radiofrequency ablation for hepatocellular carcinoma: clinical outcome and safety in elderly patients.
    Nishikawa H; Osaki Y; Iguchi E; Takeda H; Ohara Y; Sakamoto A; Hatamaru K; Henmi S; Saito S; Nasu A; Kita R; Kimura T
    J Gastrointestin Liver Dis; 2012 Dec; 21(4):397-405. PubMed ID: 23256123
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease.
    Bruera G; Cannita K; Di Giacomo D; Lamy A; Troncone G; Dal Mas A; Coletti G; Frébourg T; Sabourin JC; Tosi M; Ficorella C; Ricevuto E
    BMC Med; 2012 Nov; 10():135. PubMed ID: 23136868
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.
    Zhang H; Rakha EA; Ball GR; Spiteri I; Aleskandarany M; Paish EC; Powe DG; Macmillan RD; Caldas C; Ellis IO; Green AR
    Breast Cancer Res Treat; 2010 May; 121(1):41-51. PubMed ID: 19590950
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.
    Strautnieks SS; Byrne JA; Pawlikowska L; Cebecauerová D; Rayner A; Dutton L; Meier Y; Antoniou A; Stieger B; Arnell H; Ozçay F; Al-Hussaini HF; Bassas AF; Verkade HJ; Fischler B; Németh A; Kotalová R; Shneider BL; Cielecka-Kuszyk J; McClean P; Whitington PF; Sokal E; Jirsa M; Wali SH; Jankowska I; Pawłowska J; Mieli-Vergani G; Knisely AS; Bull LN; Thompson RJ
    Gastroenterology; 2008 Apr; 134(4):1203-14. PubMed ID: 18395098
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.